Orexo AB (FRA:C5G)
€ 1.252 -0.02 (-1.57%) Market Cap: 44.09 Mil Enterprise Value: 74.39 Mil PE Ratio: 0 PB Ratio: 21.37 GF Score: 65/100

Q3 2020 Orexo AB Earnings Call Transcript

Nov 04, 2020 / 01:00PM GMT
Release Date Price: €4.71 (+0.64%)
Operator

Hello and welcome to the Orexo Interim Report Q3 2020. (Operator Instructions)

Today, I'm pleased to present CEO, Nikolaj Sørensen; and CFO, Joseph DeFeo. Please go ahead with your meeting.

Nikolaj SÃ;rensen;publ;President;CEO
Orexo AB

¸ - ()-&

Thank you very much and welcome to this Q3 call for Orexo. Let me start with saying there's no doubt that Q3 has been a challenge for Orexo on several different accounts. But I also find that there's a lot of light in the tunnel.

If you look a little beyond the top line news in the report, I think when you look at ZUBSOLV, for example, our main product, while we are reporting a decline compared to Q2, I find that there are some very good signs that there's actually nearly no decline in the open business and where we're non-reimbursed. And even when we look at the big driver of the decline during the last year, the former exclusive contracts, that decline has actually gone down to very low numbers. And if you look at the latter part of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot